HR 2111 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Summary
This bill amends the Federal Food, Drug, and Cosmetic Act to exempt premium cigars from FDA tobacco product regulations. Premium cigars are defined using eight specific criteria, including whole tobacco leaf wrapping, hand rolling, no characterizing flavors, and minimum weight requirements. The exemption is based on findings from a 2022 National Academies report showing that premium cigars represent 1 percent of the cigar market, are used primarily by adults in specialized retail settings, and pose lower health risks than other tobacco products due to occasional use and non-inhalation patterns. The bill notes that premium cigar users are less likely to smoke other tobacco products concurrently.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
17 cosponsors
- Rep. Boyle, Brendan F. [D-PA-2] (D-PA)
- Rep. Calvert, Ken [R-CA-41] (R-CA)
- Rep. Carter, Troy A. [D-LA-2] (D-LA)
- Rep. Cuellar, Henry [D-TX-28] (D-TX)
- Rep. Diaz-Balart, Mario [R-FL-26] (R-FL)
- Rep. Espaillat, Adriano [D-NY-13] (D-NY)
- Rep. Figures, Shomari [D-AL-2] (D-AL)
- Rep. Franklin, Scott [R-FL-18] (R-FL)
- Rep. Horsford, Steven [D-NV-4] (D-NV)
- Rep. Issa, Darrell [R-CA-48] (R-CA)
- Rep. Jackson, Jonathan L. [D-IL-1] (D-IL)
- Rep. Jackson, Ronny [R-TX-13] (R-TX)
- Rep. Langworthy, Nicholas A. [R-NY-23] (R-NY)
- Rep. Panetta, Jimmy [D-CA-19] (D-CA)
- Rep. Tenney, Claudia [R-NY-24] (R-NY)
- Rep. Titus, Dina [D-NV-1] (D-NV)
- Rep. Vasquez, Gabe [D-NM-2] (D-NM)
Money behind the sponsor
Top reported contributors to Byron Donalds’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- NULL $212,903
- ENTREPRENEUR $17,899
- ANDREESSEN HOROWITZ $13,200
- ROBINHOOD MARKETS INC $12,750
- SAULSBURY INDUSTRIES $9,900
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Byron Donalds → · Outside spending →
Actions (2)
- Mar 14, 2025 Referred to the House Committee on Energy and Commerce. · house
- Mar 14, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
March 14, 2025
Mr. Donalds (for himself, Mr. Langworthy, Ms. Titus, and Mr. Panetta) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. FINDINGS.
The Congress finds the following:
(1) Premium cigars comprise only 1 percent of all cigars sold in the United States.
(2) Most manufacturers of premium cigars are family-owned small businesses.
(3) Premium cigars are typically sold in age-controlled retail establishments, such as tobacco specialty shops or cigar bars.
(4) At the request of the Food and Drug Administration and the National Institutes of Health, the National Academies of Sciences, Engineering, and Medicine (in this section referred to as the “NASEM”) convened an expert committee to examine 4 premium cigar topics: product characteristics, patterns of use, marketing and perceptions, and health effects.
(5) The NASEM expert committee produced a resulting report, published in 2022 and titled “Premium Cigars: Patterns of Use, Marketing, and Health Effects”, which among other things, identified numerous facts regarding premium cigar use.
(6) The NASEM expert committee found that premium cigars are only used by about 1 percent of the United States adult population.
(7) The NASEM expert committee found that premium cigar use is less common among youth than among other users and only 0.6 percent of those who reported smoking a premium cigar were under 18 years of age.
(8) The NASEM expert committee found that premium cigar use is less common among women, non-Hispanic Black persons, and persons with less than a high school education than other users.
(9) The NASEM expert committee found that premium cigar users are less likely to smoke cigarettes or other cigar types concurrently than other cigar type users.
(10) The NASEM expert committee found that the frequency and intensity of smoking is lower for premium cigars compared to other types of cigars and cigarettes.
(11) The NASEM expert committee found that as compared to users of other types of cigars, premium cigar users are more likely to be never or former cigarette smokers.
(12) The NASEM expert committee found that there is strongly suggestive evidence that the health consequences of premium cigar smoking overall are likely to be less than those of smoking other types of cigars because the majority of premium cigar smokers are nondaily or occasional users and because they are unlikely to inhale the smoke.
(13) The NASEM expert committee found that premium cigars are used virtually exclusively by adults, premium cigar use is extremely limited, and premium cigar use poses less physical risk than the use of other tobacco products.
(14) The definition of premium cigar used by the NASEM expert committee is broader and would encompass a larger class of cigars than the definition adopted by Judge Amit P. Mehta, of the United States District Court for the District of Columbia, in a recent decision striking the latest attempt by the Food and Drug Administration to regulate premium cigars.
(15) The narrower definition adopted by Judge Mehta is the definition that would apply if this bill were enacted.
(16) The District Court concluded that the few health risks posed by premium cigars can be regulated at the State level.
SEC. 2. EXEMPTION OF PREMIUM CIGARS FROM CERTAIN TOBACCO REGULATION IN FEDERAL FOOD, DRUG, AND COSMETIC ACT.
Section 201(rr) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(rr)) is amended by adding at the end the following:
“(6)(A) The term ‘tobacco product’ does not mean a premium cigar.
“(B) In clause (A), the term ‘premium cigar’ means a cigar that—
“(i) is wrapped in whole tobacco leaf;
“(ii) contains a 100 percent leaf tobacco binder;
“(iii) contains at least 50 percent (of the filler by weight) long filler tobacco (whole tobacco leaves that run the length of the cigar);
“(iv) is handmade or hand rolled, meaning no machinery was used apart from simple tools, such as scissors to cut the tobacco prior to rolling;
“(v) has no filter, nontobacco tip, or nontobacco mouthpiece;
“(vi) does not have a characterizing flavor other than tobacco;
“(vii) contains only tobacco, water, and vegetable gum with no other ingredients or additives; and
“(viii) weighs more than 6 pounds per 1,000 units.”. <all>
Comments